News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
3,355 Results
Type
Article (29)
Press Release (3326)
Section
Business (1335)
Career Advice (2)
Deals (180)
Drug Development (631)
FDA (95)
Job Trends (268)
News (2105)
Policy (116)
Tag
Academia (3)
Allergies (2)
Alliances (44)
Alzheimer's disease (31)
Antibody-drug conjugate (ADC) (7)
Approvals (118)
Artificial intelligence (2)
Autoimmune disease (2)
Best Places to Work (297)
Breast cancer (14)
Cancer (118)
Cardiovascular disease (10)
Career advice (1)
Cell therapy (1)
Cervical cancer (1)
Clinical research (711)
Collaboration (7)
Compensation (4)
COVID-19 (4)
C-suite (1)
Data (163)
Depression (1)
Diabetes (1)
Diagnostics (22)
Drug discovery (2)
Drug pricing (1)
Duchenne muscular dystrophy (1)
Earnings (1548)
Events (359)
FDA (169)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (5)
Generative AI (1)
Gene therapy (4)
GLP-1 (8)
Government (9)
Guidances (28)
Healthcare (85)
IgA nephropathy (3)
Infectious disease (4)
Inflammatory bowel disease (2)
IPO (162)
IRA (1)
Job creations (1)
Job search strategy (1)
Kidney cancer (2)
Layoffs (2)
Legal (1)
Lung cancer (40)
Lymphoma (15)
Manufacturing (3)
MASH (5)
Medical device (57)
Medtech (57)
Mergers & acquisitions (27)
Metabolic disorders (7)
Multiple sclerosis (8)
NASH (1)
Neurodegenerative disease (1)
Neuroscience (50)
NextGen: Class of 2026 (9)
Non-profit (4)
Obesity (1)
Opinion (1)
Ovarian cancer (4)
Pancreatic cancer (1)
Parkinson's disease (3)
Patents (1)
Patient recruitment (1)
Peanut (1)
People (9)
Phase I (108)
Phase II (214)
Phase III (427)
Pipeline (144)
Policy (1)
Postmarket research (27)
Preclinical (13)
Prostate cancer (4)
Radiopharmaceuticals (6)
Rare diseases (11)
Regulatory (164)
Reports (2)
Research institute (6)
Resumes & cover letters (1)
Rett syndrome (2)
Schizophrenia (4)
Sponsored (1)
Startups (3)
Vaccines (5)
Date
Last 7 days (3)
Last 30 days (14)
Last 365 days (419)
2026 (14)
2025 (424)
2024 (419)
2023 (423)
2022 (418)
2021 (481)
2020 (310)
2019 (202)
2018 (150)
2017 (116)
2016 (39)
2015 (73)
2014 (43)
2013 (25)
2012 (28)
2011 (23)
2010 (22)
Location
Asia (367)
Australia (14)
California (110)
Canada (27)
China (18)
Connecticut (5)
Delaware (20)
Europe (670)
Florida (13)
Georgia (2)
Illinois (11)
Indiana (20)
Japan (26)
Kansas (1)
Maryland (20)
Massachusetts (79)
Minnesota (9)
New Jersey (88)
New York (41)
North Carolina (13)
Northern California (75)
Ohio (4)
Pennsylvania (34)
South America (5)
Southern California (30)
Texas (16)
United States (492)
Utah (8)
Virginia (1)
Washington State (6)
3,355 Results for "%E2%80%9D%20target=".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sensorion Announces €60 Million Financing With a €20M Strategic Investment from Sanofi and Support from Global Healthcare Specialists To Advance Genetic Medicine Pipeline
January 28, 2026
·
15 min read
Press Releases
[Ad hoc announcement pursuant to Art. 53 LR] Roche reports strong 2025 results with 7% sales growth
January 29, 2026
·
23 min read
Press Releases
AB Science receives Japanese patent protection for the use of masitinib in progressive forms of multiple sclerosis (MS) until 2041
January 22, 2026
·
10 min read
Press Releases
ORIC® Pharmaceuticals Provides Operational Highlights for 2025 and Anticipated Upcoming Milestones
January 13, 2026
·
9 min read
Press Releases
Bial Achieves Key Milestone in Phase 2b ACTIVATE Study of BIA 28-6156 in GBA1-Associated Parkinson’s Disease
January 27, 2026
·
4 min read
Press Releases
Lilly’s Jaypirca (pirtobrutinib) significantly improved progression-free survival, reducing the risk of progression or death by 80%, versus chemoimmunotherapy in patients with treatment-naïve CLL/SLL
December 10, 2025
·
18 min read
Press Releases
RYBREVANT® (amivantamab-vmjw) longer-term results show promising and durable responses in difficult-to-treat colorectal cancer
January 12, 2026
·
36 min read
Press Releases
Ziihera® (zanidatamab-hrii) Combinations Achieve Unprecedented Results in First-Line HER2+ Locally Advanced or Metastatic GEA including more than Two Years Median Overall Survival Benefit
January 7, 2026
·
14 min read
Press Releases
Pfizer’s BRAFTOVI® Regimen with Additional Chemotherapy Backbone Increased Response Rates for Certain Patients with Metastatic Colorectal Cancer
January 12, 2026
·
19 min read
Press Releases
Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment
December 18, 2025
·
15 min read
1 of 336
Next
